OrganoBiotech, founded in 2021 from Dr. Zhang’s lab at McMaster University, is dedicated to advancing biological research with cutting-edge platform technologies. Supported by McMaster and various Canadian research bodies, the company aims to revolutionize drug discovery through advanced tissue models and generative AI for data interpretation. OrganoBiotech envisions transforming medicine validation by replicating complex biological processes with confidence and precision.